IRIS
MAZZANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.289
EU - Europa 860
AS - Asia 608
OC - Oceania 5
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.275
CN - Cina 584
IE - Irlanda 494
IT - Italia 141
FI - Finlandia 89
DE - Germania 49
UA - Ucraina 23
SE - Svezia 20
CA - Canada 14
GB - Regno Unito 10
IN - India 10
BE - Belgio 8
FR - Francia 8
NL - Olanda 6
JP - Giappone 5
RU - Federazione Russa 5
AU - Australia 4
SG - Singapore 4
BR - Brasile 2
GR - Grecia 2
MU - Mauritius 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
Totale 2.768
Salva come PNG Salva come JPEG
Città #
Dublin 492
Chandler 373
Nanjing 138
Ashburn 117
Beijing 81
Princeton 74
San Genesio Ed Uniti 74
Jacksonville 70
Lawrence 70
Helsinki 62
Medford 59
Wilmington 56
Nanchang 51
Changsha 49
Jiaxing 46
Hebei 44
Shanghai 43
Shenyang 42
Tianjin 36
Hangzhou 27
Ann Arbor 24
New York 20
Woodbridge 17
Norwalk 16
Pavia 16
Toronto 13
Seattle 11
Brussels 8
Falls Church 8
Banjara Hills 6
Fairfield 6
Boardman 5
Houston 5
Kobe 5
Washington 5
Zola Predosa 5
San Francisco 4
Chicago 3
Fuzhou 3
Jinan 3
Milan 3
Ningbo 3
Pozzuolo Martesana 3
Redmond 3
Redwood City 3
Ypsilanti 3
Zhengzhou 3
Auburn Hills 2
Dearborn 2
Desio 2
Guangzhou 2
Melbourne 2
Meppel 2
Pesaro 2
Pune 2
Verona 2
Amsterdam 1
Bareggio 1
Bari 1
Berlin 1
Bovisio Masciago 1
Cheboksary 1
Como 1
Davis 1
Des Moines 1
Drinovci 1
Dubai 1
Edinburgh 1
Enschede 1
Falkenstein 1
Formigine 1
Gavirate 1
Haifa 1
Haikou 1
Hamilton 1
Hanover 1
Izhevsk 1
Kraków 1
Lisbon 1
London 1
Natal 1
Novokuznetsk 1
Oklahoma City 1
Padova 1
Palermo 1
Paris 1
Phoenix 1
Pittsburgh 1
Rockville 1
San Jose 1
Somma Lombardo 1
Sydney 1
São Paulo 1
Taizhou 1
Tappahannock 1
Travaco Siccomario 1
Turin 1
Varenna 1
Velikiy Novgorod 1
Veruno 1
Totale 2.270
Salva come PNG Salva come JPEG
Nome #
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 114
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 88
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 66
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 60
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 60
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 59
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 58
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 57
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 57
Genetic causes of sudden cardiac death in the young. 56
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 56
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 54
Brugada Syndrome: The Endless Conundrum 53
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 53
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 46
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 46
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 46
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 45
Usefulness of exercise test in the diagnosis of short QT syndrome 45
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 44
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 44
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 44
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 43
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 43
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 43
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 43
Genetic risk stratification in cardiac arrhythmias 42
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 42
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 40
Diagnosis of Long QT Syndrome: Time to Stand Up! 39
The genetics of Long QT Syndrome 39
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 39
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 39
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 37
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 37
Inherited arrhythmias: LQTS/SQTS/CPVT 35
Indications for genetic testing in athletes and its indication in clinical practice 35
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 35
Genetic Arrhythmias (Channelopathies) 34
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 32
Novel insights in the natural history of Short QT Syndrome 32
Is there a role for genetics in the prevention of sudden cardiac death? 31
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 30
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 30
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 30
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 29
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 29
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 29
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 28
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 28
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 28
Risk Stratification in the Long QT Syndrome 27
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 26
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 26
Long-term follow-up of patients with short QT syndrome 26
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 26
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 25
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 25
Personalized therapies for cardiac channelopathies 25
Repeat adverse events long after percutaneous coronary revascularization in diabetics 25
Dilated cardiomyopathy 25
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 23
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 23
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 23
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 22
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 22
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 22
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 21
Short QT syndromes 21
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 21
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 19
The interpretation of genetic tests in inherited cardiovascular diseases 18
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 17
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 16
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 16
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 15
Brugada syndrome and job fitness: report of three cases 15
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 15
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 14
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 14
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 12
Totale 2.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 2 2 2
2019/2020566 186 273 1 4 2 4 0 15 19 28 33 1
2020/2021184 10 19 1 5 0 17 6 39 58 17 9 3
2021/2022321 0 7 14 0 7 13 3 19 15 24 46 173
2022/20231.171 146 92 19 69 86 101 0 54 564 3 22 15
2023/2024396 54 65 21 43 33 98 45 26 7 4 0 0
Totale 2.897